MATHEMATICAL MODEL OF REIMBURSEMENT DECISION MAKING IN RUSSIA. RESULTS OF VIM LIST FOR 2016
Background: In 2014 we firstly analyzed the formalized system (points and expert opinions) of drug inclusion and exclusion into the reimbursement lists in Russian Federation. The liner mathematical model of decision making was developed and adopted.Aim. Update the existing model using the results of...
Saved in:
Main Authors: | A. S. Kolbin (Author), A. V. Prasolov (Author), E. A. Maksimkina (Author), Yu. E. Balykina (Author), Z. M. Golant (Author), Yu. S. Polushin (Author), A. A. Kurylev (Author), I. A. Vilyum (Author) |
---|---|
Format: | Book |
Published: |
IRBIS LLC,
2016-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
What is the role of antineoplastic drug safety in reimbursement decision making?
by: A. S. Kolbin, et al.
Published: (2018) -
Analysis of effectiveness criteria in pharmacoeconomic studies of hypoglycemic drugs proposed for inclusion into the essential drug list in 2014-2016 in Russia
by: A. A. Mosikyan, et al.
Published: (2018) -
Socio-economic burden of chronic migraine in Russia
by: A. A. Kolbin, et al.
Published: (2019) -
The social-economic burden of spinal muscular atrophy in Russia
by: A. S. Kolbin, et al.
Published: (2021) -
Modeling microbial drug-resistance: from mathematics to pharmacoeconomics
by: Yu. M. Gomon, et al.
Published: (2018)